박무림 교수 연구실
article|
인용수 41
·2018
18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System
Sung‐Hoon Jung, Seong Young Kwon, Jung‐Joon Min, Hee‐Seung Bom, Seo‐Yeon Ahn, Seung-Yeon Jung, Seung-Shin Lee, Moo‐Rim Park, Deok‐Hwan Yang, Jae‐Sook Ahn, Hyeoung‐Joon Kim, Je‐Jung Lee
IF 7.6European Journal of Nuclear Medicine and Molecular Imaging
키워드
MedicinePET-CTStage (stratigraphy)Nuclear medicineMultiple myelomaPositron emission tomographyOverall survivalRetrospective cohort studyRadiologyMultivariate analysis